<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1766317/" ref="ordinalpos=3581&amp;ncbi_uid=797694&amp;link_uid=PMC1766317" image-link="/pmc/articles/PMC1766317/figure/F5/" class="imagepopup">Fig. 5. From: CARMA3/Bcl10/MALT1-dependent NF-?B activation mediates angiotensin II-responsive inflammatory <span class="highlight" style="background-color:">signaling</span> in nonimmune cells. </a></div><br /><div class="p4l_captionBody">Model: A similar CARMA-Bcl10-MALT1 signaling pathway mediates NF-κB activation in response to antigen receptor stimulation in lymphocytes and AT1R stimulation in liver cells. (Left) In lymphocytes, antigen-dependent NF-κB activation leads to cytokine production and cellular proliferation. (Right) In liver, Ang II-dependent NF-κB activation leads to a variety of proinflammatory effects that are implicated in the development of hepatic fibrosis/cirrhosis.</div></div>